26 Amendments of Annie SCHREIJER-PIERIK related to 2017/2254(INI)
Amendment 13 #
Motion for a resolution
Citation 16 a (new)
Citation 16 a (new)
– having regard to the ECDC report 2016 on AMR surveillance in Europe,
Amendment 42 #
Motion for a resolution
Recital C
Recital C
C. whereas healthcare-associated infections (HAI) are often due to antibiotic-resistant bacteria; whereas the European Centre for Disease Prevention and Control (ECDC) estimates that approximately 4 million patients acquire a HAI each year in the EU and that approximatelyt least 37 000 deaths result directly from these infections; whereas there is a possibility that the number of deaths could be even higher than this; whereas the previously submitted figure of 25 000 deaths in the Union proved to be a serious underestimate;
Amendment 56 #
Draft opinion
Paragraph 4
Paragraph 4
4. Calls for further research and development into new antimicrobials and encourages alternatives to be investigated, including the development of more sustainable farming systems based on less intensive farming models;
Amendment 88 #
Motion for a resolution
Paragraph 1 a (new)
Paragraph 1 a (new)
1a. Deplores the fact, in this context, that the Commission did not propose a strategic approach to the pollution of water with pharmaceuticals sooner, as required by Directive 2013/39/EU1 a; urges the Commission and Member States therefore, without delay, to draw up a European strategy for tackling drug residues in water and the environment, devoting sufficient attention to monitoring, data collection and better analysis of the impact of AMR on water resources and the aquatic ecosystem; draws attention to the usefulness of an integrated chain approach to drug residues and antimicrobial resistance in the environment2 a; _________________ 1a Article 8c. 2a As formulated in the Netherlands by the Ministry of Infrastructure and Public Works, the National Institute for Public Health and the Environment (RIVM), the water industry and water boards.
Amendment 90 #
Draft opinion
Paragraph 6 a (new)
Paragraph 6 a (new)
6a. Notes that the European One Health Action Plan against Antimicrobial Resistance (AMR) observes that immunisation by means of vaccination is a cost-effective health intervention in efforts to combat AMR1 a and that, in the Action Plan, the Commission announces incentives to promote the use of diagnostics, antimicrobial alternatives and vaccines2 a, but that relatively higher costs of diagnosis, antimicrobial alternatives and vaccination as compared with conventional antibiotics are an obstacle to raising the vaccination rate, as the Action Plan aims to do3 a; underlines that various Member States already regard vaccination as an important policy measure, both to prevent outbreaks of animal diseases across borders and to restrict further risks of contagion for the European agricultural market, and have introduced it; _________________ 1a European Commission (29 June 2017), A European One Health Action Plan against Antimicrobial Resistance (AMR), p. 10. 2a Ibid., p. 12. 3a Ibid., p. 15.
Amendment 94 #
Draft opinion
Paragraph 6 b (new)
Paragraph 6 b (new)
6b. Calls on the Member States to take further steps to raise the vaccination rate in the industry and thus tackle these diseases and antibiotic resistance cost- effectively; calls on the Commission and Member States — including in the context of the reform of the Common Agricultural Policy — to bring about more synergies and, in accordance with the findings set out in the Commission’s One Health Action Plan against antimicrobial resistance (AMR), to provide financial rewards, incentives and support for livestock farmers who can demonstrate that they have reduced their use of antibiotics and achieved a high vaccination rate of their animals;
Amendment 96 #
Motion for a resolution
Paragraph 1 b (new)
Paragraph 1 b (new)
1b. Underlines the importance of exchanges of best practices between Member States and the coordination of such exchanges by the Commission; welcomes in this context the reduction of the use of antibiotics in animal husbandry in the Netherlands by 64.4% in the period 2009-2016 and the stated national ambition to further reduce it by 2020; calls on the Commission and Member States to apply this example of public- private cooperation between public authorities, industries, scientists and veterinary surgeons in other parts of the Union as well;
Amendment 98 #
Motion for a resolution
Paragraph 1 c (new)
Paragraph 1 c (new)
1c. Draws attention furthermore to recent scientific research results (February 2018) which show that ESBLs (Extended Spectrum Bèta-Lactamases) are transferred to people from livestock farming and meat consumption only to a limited extent and that the transmission of ESBLs mainly occurs from person to person1 a; _________________ 1a Mevius, D. et al. (2018). Rapport ESBL-Attributieanalyse(ESBLAT). Op zoek naar de bronnen van antibioticaresistentie bij de mens. http://www.1health4food.nl/esblat (Wageningen University, Utrecht University, RIVM)
Amendment 99 #
Motion for a resolution
Paragraph 1 d (new)
Paragraph 1 d (new)
1d. Calls on the Commission and Member States, on account of this recent research1 a, to take care and maintain a sense of proportion in adopting measures, and to carefully assess and classify 'antibiotics' and 'antimicrobial resistance' in all relevant legislation in order to avoid unnecessarily restricting the availability of remedies to combat certain protozoa, such as coccidia, in European livestock farming and thus unintentionally causing an increase in the risks of contamination of human beings with dangerous bacteria such as salmonella and microbes from food; _________________ 1a Mevius, D. et al. (2018). Rapport ESBL-Attributieanalyse(ESBLAT). Identify the sources of antibiotic resistance in humans. http://www.1health4food.nl/esblat
Amendment 103 #
Draft opinion
Paragraph 7 a (new)
Paragraph 7 a (new)
7a. Underlines the importance of exchanges of best practices between Member States and the coordination of such exchanges by the Commission; welcomes in this context the reduction of the use of antibiotics in animal husbandry in the Netherlands by 64.4% in the period 2009-2016 and the stated ambition to further reduce it by 2020; calls on the Commission to recommend this example of public-private cooperation between public authorities, industries, scientists and veterinary surgeons in other parts of the Union as well;
Amendment 107 #
Draft opinion
Paragraph 7 b (new)
Paragraph 7 b (new)
7b. Draws attention to the latest research (February 2018) demonstrating that ESBLs (Extended Spectrum Beta Lactamases) are transferred to people only to a limited extent as a result of livestock farming or eating meat, mainly being transferred from person to person1 a; _________________ 1a Mevius, D. et al. (2018). Rapport ESBL-Attributieanalyse (ESBLAT). Op zoek naar de bronnen van antibioticaresistentie bij de mens. http://www.1health4food.nl/esblat
Amendment 109 #
Draft opinion
Paragraph 7 c (new)
Paragraph 7 c (new)
7c. Calls on the Commission and Member States, in view of this recent research, to take care and maintain a sense of proportion in adopting measures, and to carefully assess and classify 'antibiotics' and 'antimicrobial resistance' in order to avoid unnecessarily restricting the availability of products to combat certain protozoa, such as coccidia, in European livestock farming;
Amendment 113 #
Motion for a resolution
Paragraph 2 a (new)
Paragraph 2 a (new)
2a. Calls on the Commission in cooperation with the Member States to launch an EU-wide information campaign for consumers and businesses on aquaculture in general and in particular the differences between the stringent and comprehensive standards on the European market and the standards applicable to imported products in third countries, with particular emphasis on the problems caused for food safety and public health by the introduction into the Union of particularly resistant micro- organisms and antimicrobial resistance (AMR);
Amendment 120 #
Draft opinion
Paragraph 8
Paragraph 8
8. Underlines the need to changeat, in their business culture employed bymodels, veterinary medicine producers, which encourages the use and overuse of certain medicines in order to generate profits should take into account the threats posed by AMR; stresses the need for more research and further innovation in the pharmaceutical sector;
Amendment 129 #
Draft opinion
Paragraph 9
Paragraph 9
9. Notes that the use of antibiotics as growth promoters in food-producing animals has been banned in the EU since 2006; calls onurges the Commission to enforce this ban as a impose that prohibition as a strict preconditionality to for all foods importsed from third countries throughunder Free Trade Agreements with a view to ensuring a level playing field and in order not to leave any loopholes in the implementation of the Action Plan against antimicrobial resistance;
Amendment 162 #
Motion for a resolution
Paragraph 5 a (new)
Paragraph 5 a (new)
5a. Urges the Commission and Member States to submit regular and accurate reports on the number of confirmed cases of AMR in humans, as well as correct and up-to-date AMR mortality statistics;
Amendment 223 #
Motion for a resolution
Paragraph 11
Paragraph 11
Amendment 240 #
Motion for a resolution
Paragraph 11 a (new)
Paragraph 11 a (new)
11a. Recognises the positive role of veterinary medicines in improving animal welfare; stresses, at the same time, other ways in which animal welfare and animal health can be promoted in practice, such as with regard to their housing, taking into account the impact on cost and a level playing field;
Amendment 260 #
Motion for a resolution
Paragraph 12 a (new)
Paragraph 12 a (new)
12a. Stresses that the European One Health Action Plan against Antimicrobial Resistance (AMR) observes that immunisation by means of vaccination is a cost-effective health intervention in efforts to combat AMR1 a1 a and that, in the Action Plan, the Commission announces incentives to promote the use of diagnostics, antimicrobial alternatives and vaccines2 a2 a, but that relatively higher costs of diagnosis, antimicrobial alternatives and vaccination as compared with conventional antibiotics are an obstacle to raising the vaccination rate, as the Action Plan aims to do3 a; underlines that various Member States already regard vaccination as an important policy measure both to prevent outbreaks of animal diseases across borders and to restrict further risks of contagion for the European agricultural market and have introduced it; _________________ 1a European Commission (29 June 2017), A European One Health Action Plan against Antimicrobial Resistance (AMR), p. 10. 2a Ibid., p. 12. 3a Ibid., p. 15.
Amendment 266 #
Motion for a resolution
Paragraph 12 b (new)
Paragraph 12 b (new)
12b. Calls on the Member States to take further steps to raise the vaccination rate in human and veterinary health care and thus tackle diseases and antibiotic resistance cost-effectively; calls on the Commission and Member States — including in the context of the reform of the Common Agricultural Policy — to bring about more synergies and, in accordance with the findings set out in its One Health Action Plan against antimicrobial resistance (AMR), to provide effective financial incentives and support for livestock farmers who can demonstrate that they have significantly reduced the use of antibiotics and achieved a high vaccination rate of their animals or livestock;
Amendment 281 #
Motion for a resolution
Paragraph 13 a (new)
Paragraph 13 a (new)
13a. Stresses the need for more information for consumers and patients on handling pharmaceutical residues and medical waste intelligently;
Amendment 303 #
Motion for a resolution
Paragraph 14 a (new)
Paragraph 14 a (new)
14a. Points out in this connection that a thorough ex-ante assessment of the social costs of an ‘end of pipe’ approach is necessary;
Amendment 306 #
Motion for a resolution
Paragraph 14 b (new)
Paragraph 14 b (new)
14b. Calls on the Commission and Member States to encourage the development of sustainable medicinal products with a low impact on the environment and water and to encourage further innovation in the pharmaceutical industry in this regard;
Amendment 416 #
Motion for a resolution
Paragraph 26
Paragraph 26
26. Notes that AMR is of serious concern in many poverty-related and neglected diseases (PRNDs), including HIV/AIDS, malaria and tuberculosis (TB); highlights that about 29 % of deaths caused by AMR are due to drug-resistant TB, and calls on the Commission and the Member States, as a matter of urgency, to increase their support to research forinto and application of health tools to address PRNDs affected by AMR;
Amendment 428 #
Motion for a resolution
Paragraph 27
Paragraph 27
27. Calls on the Commission to advocate EU standards and measures for tackling AMR in trade agreements; notes that the use of antibiotics as growth promoters in food-producing animals has already been banned in the European Union since 2006; demands that the Commission impose that prohibition as a precondition for all foods imported from third countries under Free Trade Agreements with a view to ensuring a level playing field for European livestock farming and aquaculture and in order not to leave any loopholes in the implementation of the approach to antimicrobial resistance;
Amendment 442 #
Motion for a resolution
Paragraph 28 a (new)
Paragraph 28 a (new)
28a. Calls on the Commission and Member States to take stronger measures against the sale of large consignments of antimicrobials, in particular critical human antibiotics, at dumping prices;